Pancreatic Cancer Research

ResearcherUSA Mitchell Cancer InstituteNo recent work listed

Girijesh Kumar Patel

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4660-5876; OpenAlex author ID A5031950018. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2016: 1 paper · 2017: 2 papers · 2018: none · 2019: 1 paper · 2020: 1 paper

Papers 5

  1. Co-targeting of CXCR4 and hedgehog pathways disrupts tumor-stromal crosstalk and improves chemotherapeutic efficacy in pancreatic cancer. Co-author DOI 10.1074/jbc.ra119.011748↗
  2. Exosomal markers (CD63 and CD9) expression and their prognostic significance using immunohistochemistry in patients with pancreatic ductal adenocarcinoma. First author DOI 10.21037/jgo.2018.07.02↗
  3. Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enz… Co-author DOI 10.1038/bjc.2017.18↗
  4. Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward. Co-author DOI 10.3390/ijms18040779↗
  5. Pancreatic Cancer Exosomes: Shedding Off for a Meaningful Journey. Co-author DOI 10.4172/2165-7092.1000e148↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Seema Singh · 4 shared papers, 2017–2020 · strength 0.32
  2. Moh'd M. Khushman · 4 shared papers, 2017–2020 · strength 0.32
  3. Ajay P. Singh · 4 shared papers, 2017–2020 · strength 0.32
  4. Mary C. Patton · 3 shared papers, 2016–2019 · strength 0.27
  5. Mohammad Aslam Khan · 3 shared papers, 2017–2020 · strength 0.25
  6. Arun Bhardwaj · 3 shared papers, 2017–2019 · strength 0.22
  7. Sanjeev K. Srivastava · 2 shared papers, 2017–2020 · strength 0.18
  8. Shafquat Azim · 1 shared paper, 2017 · strength 0.07
  9. Marcus Chuan Beng Tan · 1 shared paper, 2019 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.